Korea S.E.
18:00:00 2023-07-19 EDT
5-day change
1st Jan Change
2,080
KRW
-9.96%
-.--%
-.--%
Tranche Update on Cheil Bio Co., Ltd.'s Equity Buyback Plan announced on March 10, 2017.
June 12, 2017 at 02:37 am
From March 10, 2017 to March 31, 2017, the company has repurchased 143,862 shares, representing 0.96% for KRW 546.84 million. With this, the company has completed the repurchase of 143,862 shares, representing 0.96% for KRW 546.84 million under the buyback announced on March 10, 2017.
Cheilbio Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024
05-16
CI
Cheilbio Co., Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023
11-14
CI
Cheilbio Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023
23-05-15
CI
Cheilbio Co., Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022
22-11-11
CI
Tranche Update on Cheilbio Co., Ltd.'s Equity Buyback Plan announced on April 13, 2022.
22-10-12
CI
Tranche Update on Cheilbio Co., Ltd.'s Equity Buyback Plan announced on April 13, 2022.
22-10-12
CI
Tranche Update on Cheilbio Co., Ltd.'s Equity Buyback Plan announced on April 13, 2022.
22-10-12
CI
Cheilbio Co., Ltd.'s Equity Buyback announced on April 13, 2022, has expired with 1,246,452 shares, representing 4.41% for KRW 2,999.36 million.
22-10-11
CI
Cheilbio Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2022
22-05-16
CI
Cheilbio Co., Ltd. announces an Equity Buyback for KRW 3,000 million worth of its shares.
22-04-12
CI
Cheilbio Co., Ltd. authorizes a Buyback Plan.
22-04-12
CI
Cheilbio Co., Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021
21-11-15
CI
Tranche Update on Cheilbio Co., Ltd.'s Equity Buyback Plan announced on March 23, 2018.
18-09-27
CI
Tranche Update on Cheilbio Co., Ltd.'s Equity Buyback Plan announced on March 23, 2018.
18-09-27
CI
Cheilbio Co., Ltd.'s Equity Buyback announced on March 23, 2018 has expired with 495,436 shares for KRW 1,984.53 million.
18-09-26
CI
Tranche Update on Cheilbio Co., Ltd.'s Equity Buyback Plan announced on March 23, 2018.
18-06-26
CI
Cheilbio Co., Ltd. announces an Equity Buyback for KRW 2,000 million worth of its shares.
18-03-23
CI
Cheilbio Co., Ltd. authorizes a Buyback Plan.
18-03-22
CI
Tranche Update on Cheilbio Co., Ltd.'s Equity Buyback Plan announced on July 5, 2017.
18-01-04
CI
Cheil Bio Co., Ltd.’s Equity Buyback announced on July 5, 2017 has expired.
18-01-03
CI
Tranche Update on Cheilbio Co., Ltd.'s Equity Buyback Plan announced on July 5, 2017.
17-10-09
CI
Cheil Bio Co., Ltd.'s Equity Buyback announced on March 10, 2017, has expired.
17-09-07
CI
Cheil Bio Co., Ltd. announces an Equity Buyback for KRW 2,000 million worth of its shares.
17-07-04
CI
Cheil Bio Co., Ltd. authorizes a Buyback Plan.
17-07-04
CI
Tranche Update on Cheil Bio Co., Ltd.'s Equity Buyback Plan announced on March 10, 2017.
17-06-12
CI
Duration Auto. 2 months 3 months 6 months 9 months 1 year 2 years 5 years 10 years Max.
Period Day Week
More charts
Cheilbio Co., Ltd. is a Korea-based company engaged in the manufacturing of veterinary drugs. The Company's offerings consist of antibiotics, antimicrobials, lactobacillus, enzyme preparations, parasiticides, antiseptics, organic trace minerals, vaccines, diagnostic kits including enzyme-linked immunosorbent assay (ELISA) test kits, virus test kits and deoxyribonucleic acid (DNA) kits, as well as feed additives. The Companyâs products are used for cattle, pigs, chickens, pets and other animals. It supplies its products mainly to the domestic market.
More about the company
1st Jan change
Capi.
-.--% 40.63M +18.66% 8.74B +23.75% 3.67B -0.42% 3.25B +18.07% 1.73B -16.99% 1.38B -0.39% 1.31B -26.05% 1.24B -17.86% 1.07B -6.77% 976M
Veterinary Drugs
+951% of historical
More than 20 years
Our Experts
OUR EXPERTS ARE HERE FOR YOU
Monday - Friday 9am-12pm / 2pm-6pm GMT + 1
CHEILBIO CO., LTD. 
